Company Filing History:
Years Active: 2018
Title: Yevgen Vengrenyuk: Innovator in Prostate Cancer Risk Assessment
Introduction
Yevgen Vengrenyuk is a notable inventor based in Mamaroneck, NY (US). He has made significant contributions to the field of medical technology, particularly in the area of prostate cancer risk assessment. His innovative approach combines clinical, molecular, and morphometric information to enhance predictive models for medical conditions.
Latest Patents
Yevgen Vengrenyuk holds 1 patent for a method and system designed to determine the risk of occurrence of prostate cancer. This patent utilizes clinical information, molecular data, and computer-generated morphometric information to create a predictive model. The model is particularly focused on predicting the risk of prostate cancer progression in patients. Key features of the model include preoperative PSA levels, dominant Gleason Grade, Gleason Score, and various morphometric measurements derived from image analysis of tissue samples.
Career Highlights
Vengrenyuk is associated with the Fundação D. Anna De Sommer Champalimaud e Dr. Carlos Montez Champalimaud, where he continues to work on advancing medical technologies. His research aims to improve the accuracy of prostate cancer risk assessments, ultimately benefiting patient outcomes.
Collaborations
Some of his notable coworkers include Michael Donovan and Faisal Khan, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Yevgen Vengrenyuk's innovative work in the field of prostate cancer risk assessment exemplifies the importance of integrating various types of information to enhance predictive models. His contributions are paving the way for advancements in medical technology and patient care.